Aerovate Therapeutics stockholders elect directors and ratify KPMG as auditor at 2024 annual meeting

Jade Biosciences, Inc.

Stockholders elected David Grayzel, M.D. and Maha Katabi, Ph.D. as Class III directors with 24.4M and 25.9M votes for, respectively.
Ratification of KPMG LLP as independent auditor for FY 2024 was approved with 28,074,033 votes for, 511 against, 105 abstain.
The meeting was held on June 5, 2024; 28,737,381 shares were outstanding and entitled to vote as of April 12, 2024 record date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.